国药现代：子公司国药工业盐酸氯胺酮原料药获上市批准

Group 1 - The core point of the article is that China National Pharmaceutical Group Modern has received approval from the National Medical Products Administration for the market application of the raw material drug ketamine hydrochloride [1] - Ketamine hydrochloride is a intravenous anesthetic that can be used as a sole anesthetic for diagnostic and surgical procedures without muscle relaxation, and can also be used for inducing general anesthesia or as a supplement to other anesthetics [1] - The cumulative R&D investment by China National Pharmaceutical Group Industrial for this project is approximately 7.521 million yuan [1] Group 2 - Other domestic companies with registered status "A" for ketamine hydrochloride raw materials include Anhui Wanhe Pharmaceutical Co., Ltd. and Jiangsu Hengrui Medicine Co., Ltd. [1]